These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7289750)

  • 1. [Trial of nicergoline in arteriopathies of the lower limbs (apropos of 33 cases)].
    Debaert M; Ribet M; Quandalle P
    Lille Med; 1981 Mar; 26(3):140-3. PubMed ID: 7289750
    [No Abstract]   [Full Text] [Related]  

  • 2. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
    Quiroli A
    Minerva Cardioangiol; 1980 Dec; 28(12):793-804. PubMed ID: 6111767
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
    Dauverchain J
    Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nicergoline in acute myocardial infarction with diastolic hypertension.
    Triulzi E; Devizzi S; Margonato A
    Farmaco Prat; 1981 Oct; 36(10):449-55. PubMed ID: 7308417
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical use of a new vasoactive drug : nicergoline].
    Mellini M
    Minerva Med; 1973 May; 64(34):1844-53. PubMed ID: 4719381
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and rheographic results of nicergoline in the treatment of arteritis of the lower extremities].
    Schrub JC; Courtois H; Philippe JC; Boismare F
    Therapie; 1975; 30(3):407-15. PubMed ID: 1224362
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G
    Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of an alpha-adrenergic blocking agent (nicergoline) in the treatment of diabetic angiopathy of lower limbs.
    Calvagno M
    Farmaco Prat; 1982 Jun; 37(6):200-5. PubMed ID: 7106277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
    Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
    Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of nicergoline (IDB-1076) in the treatment of mild to moderate systemic arterial hypertension in adults and in the aged].
    Rinaldi G; Nieri A; Saponati G
    Minerva Cardioangiol; 1987 Oct; 35(10):573-83. PubMed ID: 3438004
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic activity of nicergoline in cerebrovascular syndromes].
    Toni E
    Minerva Med; 1973 Nov; 64(84):4466-73. PubMed ID: 4771472
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebrovascular disorders : facial thermography as a means to evaluate the therapeutic effectiveness of nicergoline].
    Sbarbaro V; Zardini GB; Morgante R; Mora L; Acciarri L; Pistolesi GF
    Farmaco Prat; 1976 Nov; 31(11):549-60. PubMed ID: 1017468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous effect of nicergoline in arterial hypertension].
    Levenson JA; Roland E; Toto Mou Kouo J; Simon A; Safar M
    Rev Med Interne; 1980; 1(1):123-6. PubMed ID: 7232904
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of arterial hypertension in the elderly with an alpha-blocker: nicergoline (author's transl)].
    Forette F; Varin D; Henry JF; Hervy MP
    Nouv Presse Med; 1980 Dec; 9(48):3685-8. PubMed ID: 7005872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
    Shtok VN; Varlamova IV; Fedorova NV; Timurbaator
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1333-8. PubMed ID: 4072531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of injectable sermion in otologic diseases].
    Gaillard J; Dubreuil C
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1979 Sep; 28(7):477-80. PubMed ID: 41025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
    Kugler JE; Meurer-Krüll BC
    Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
    Blaha L; Burkard G; Lehrl S; Kapinas K
    Arzneimittelforschung; 1979; 29(8a):1295-301. PubMed ID: 395955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.